RCMI Coordinating Center (RCMI CC) Header Logo

David Calhoun

TitleInvestigator / Area Leader
InstitutionCity College, CUNY
AddressCity College, CUNY, Marshak Science Building
Covenant Avenue at 138th Street
New York NY 10031
Phone_
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Girard AA, Denney TS, Gupta H, Dell'Italia LJ, Calhoun DA, Oparil S, Sharifov OF, Lloyd SG. Spironolactone improves left atrial function and atrioventricular coupling in patients with resistant hypertension. Int J Cardiovasc Imaging. 2024 Mar; 40(3):487-497. PMID: 38123867.
      Citations: 1     Fields:    Translation:Humans
    2. Matanes F, Siddiqui M, Velasco A, Sharifov O, Kreps E, Dudenbostel T, Judd EK, Zhang B, Lloyd SG, Oparil S, Calhoun DA. Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension. J Clin Hypertens (Greenwich). 2023 05; 25(5):416-425. PMID: 37013369.
      Citations: 1     Fields:    Translation:Humans
    3. Matanes F, Khan MB, Siddiqui M, Dudenbostel T, Calhoun D, Oparil S. An Update on Refractory Hypertension. Curr Hypertens Rep. 2022 07; 24(7):225-234. PMID: 35384577.
      Citations: 9     Fields:    Translation:Humans
    4. Gamble FN, Aufan MR, Sharifov OF, Williams LJ, Reighard S, Calhoun DA, Gupta H, Dell'Italia LJ, Denney TS, Lloyd SG. Diastolic function: modeling left ventricular untwisting as a damped harmonic oscillator. Physiol Meas. 2022 03 07; 43(2). PMID: 35073533.
      Citations:    Fields:    Translation:Humans
    5. Kwon Y, Baruch M, Stafford PL, Bonner H, Cho Y, Mazimba S, Logan JG, Shimbo D, Park SH, Lin GM, Azarbarzin A, Calhoun DA, Berry R, Carey RM. Elucidation of obstructive sleep apnoea related blood pressure surge using a novel continuous beat-to-beat blood pressure monitoring system. J Hypertens. 2022 03 01; 40(3):520-527. PMID: 34751170.
      Citations: 2     Fields:    Translation:Humans
    6. Butts B, Brown JA, Denney TS, Ballinger S, Lloyd SG, Oparil S, Sanders P, Merriman TR, Gaffo A, Singh J, Kelley EE, Calhoun DA, Dell'Italia LJ. Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension. Hypertension. 2022 04; 79(4):775-784. PMID: 35164526.
      Citations: 5     Fields:    Translation:HumansCells
    7. Thomas SJ, Calhoun D. Continuous positive airway pressure use: how much is enough? Hypertens Res. 2022 03; 45(3):533-534. PMID: 34952954.
      Citations: 1     Fields:    
    8. Aryal SR, Siddiqui M, Sharifov OF, Coffin MD, Zhang B, Gaddam KK, Gupta H, Denney TS, Dell'Italia LJ, Oparil S, Calhoun DA, Lloyd SG. Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change. J Am Heart Assoc. 2021 09 07; 10(17):e019434. PMID: 34459249.
      Citations: 8     Fields:    Translation:Humans
    9. Dudenbostel T, Li P, Calhoun DA. Paradoxical Increase of 24-Hour Urinary Aldosterone Levels in Obese Patients With Resistant Hypertension on a High Salt Diet. Am J Hypertens. 2021 06 22; 34(6):600-608. PMID: 33290515.
      Citations: 4     Fields:    Translation:Humans
    10. Gaffo AL, Calhoun DA, Rahn EJ, Oparil S, Li P, Dudenbostel T, Feig DI, Redden DT, Muntner P, Foster PJ, Biggers-Clark SR, Mudano A, Sattui SE, Saddekni MB, Bridges SL, Saag KG. Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial. Arthritis Rheumatol. 2021 08; 73(8):1514-1522. PMID: 33779064.
      Citations: 13     Fields:    Translation:Humans
    11. Santillan MK, Becker RC, Calhoun DA, Cowley AW, Flynn JT, Grobe JL, Kotchen TA, Lackland DT, Leslie KK, Liang M, Mattson DL, Meyers KE, Mitsnefes MM, Muntner PM, Pierce GL, Pollock JS, Sigmund CD, Thomas SJ, Urbina EM, Kidambi S. Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience. Hypertension. 2021 06; 77(6):1857-1866. PMID: 33934625.
      Citations: 1     Fields:    Translation:Humans
    12. Cai A, Liu L, Siddiqui M, Zhou D, Chen J, Calhoun DA, Tang S, Zhou Y, Feng Y. Uric Acid Is Not Associated With Blood Pressure Phenotypes and Target Organ Damage According to Blood Pressure Phenotypes. Am J Hypertens. 2021 02 18; 34(1):64-72. PMID: 32812633.
      Citations: 2     Fields:    Translation:Humans
    13. Thomas SJ, Siddiqui M, Judd E, Moore D, Harding SM, Oparil S, Calhoun D. Obstructive sleep apnea is more severe in men but not women with refractory hypertension compared with controlled resistant hypertension. J Hypertens. 2021 02 01; 39(2):286-291. PMID: 33031172.
      Citations:    Fields:    Translation:Humans
    14. Siddiqui M, Judd EK, Zhang B, Dudenbostel T, Carey RM, Oparil S, Calhoun DA. Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion. Hypertension. 2021 02; 77(2):435-444. PMID: 33280407.
      Citations: 2     Fields:    Translation:Humans
    15. Thomas SJ, Johnson DA, Guo N, Abdalla M, Booth JN, Spruill TM, Jackson CL, Yano Y, Sims M, Calhoun D, Muntner P, Redline S. Association of Obstructive Sleep Apnea With Nighttime Blood Pressure in African Americans: The Jackson Heart Study. Am J Hypertens. 2020 10 21; 33(10):949-957. PMID: 32492711.
      Citations: 4     Fields:    Translation:Humans
    16. Langford AT, Akinyelure OP, Moore TL, Howard G, Min YI, Hillegass WB, Bress AP, Tajeu GS, Butler M, Jaeger BC, Yano Y, Shimbo D, Ogedegbe G, Calhoun D, Booth JN, Muntner P. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study. Hypertension. 2020 11; 76(5):1600-1607. PMID: 32924633.
      Citations: 7     Fields:    Translation:Humans
    17. Siddiqui M, Bhatt H, Judd EK, Oparil S, Calhoun DA. Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept Study. Am J Hypertens. 2020 08 04; 33(8):741-747. PMID: 32179903.
      Citations: 7     Fields:    Translation:Humans
    18. An J, Sim JJ, Calhoun DA, Liu R, Wei R, Zhou H, Luong T, Reynolds K. Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system. J Hypertens. 2020 08; 38(8):1603-1611. PMID: 32251197.
      Citations: 6     Fields:    Translation:Humans
    19. Stokes ES, Gilchrist ML, Calhoun DH. Prediction of improved therapeutics for fabry disease patients generated by mutagenesis of the a-galactosidase A active site, dimer interface, and glycosylation region. Protein Expr Purif. 2020 11; 175:105710. PMID: 32738442.
      Citations: 2     Fields:    Translation:HumansCells
    20. Siddiqui M, Dominiczak AF, Touyz RM, Carey RM, Basile J, Heslin MJ, Winokur T, Calhoun DA, Oparil S, Dudenbostel T. Case of Episodic and Positional Hypertension: Diagnosis and Treatment. Hypertension. 2020 09; 76(3):614-621. PMID: 32683905.
      Citations:    Fields:    Translation:Humans
    21. Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A. The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. Ann Intern Med. 2020 07 07; 173(1):10-20. PMID: 32449886.
      Citations: 145     Fields:    Translation:Humans
    22. Kwon Y, Stafford PL, Lim DC, Park S, Kim SH, Berry RB, Calhoun DA. Blood pressure monitoring in sleep: time to wake up. Blood Press Monit. 2020 Apr; 25(2):61-68. PMID: 31855900.
      Citations: 15     Fields:    Translation:Humans
    23. Thomas SJ, Booth JN, Jaeger BC, Hubbard D, Sakhuja S, Abdalla M, Lloyd-Jones DM, Buysse DJ, Lewis CE, Shikany JM, Schwartz JE, Shimbo D, Calhoun D, Muntner P, Carnethon MR. Association of Sleep Characteristics With Nocturnal Hypertension and Nondipping Blood Pressure in the CARDIA Study. J Am Heart Assoc. 2020 04 07; 9(7):e015062. PMID: 32188307.
      Citations: 16     Fields:    Translation:Humans
    24. Sharman JE, O'Brien E, Alpert B, Schutte AE, Delles C, Olsen MH, Asmar R, Atkins N, Barbosa E, Calhoun D, Campbell NRC, Chalmers J, Benjamin I, Jennings G, Laurent S, Boutouyrie P, Lopez-Jaramillo P, McManus RJ, Mihailidou AS, Ordunez P, Padwal R, Palatini P, Parati G, Poulter N, Rakotz MK, Rosendorff C, Saladini F, Scuteri A, Barroso WS, Cho MC, Sung KC, Townsend RR, Wang JG, Hansen TW, Wozniak G, Stergiou G. [Lancet Commission on Hypertension Group position statement on the global improvement of accuracy standards for devices that measure blood pressurePosicionamento do Grupo da Lancet Commission on Hypertension sobre a melhoria global dos padr?es de acur?cia para aparelhos que medem a press?o arterial]. Rev Panam Salud Publica. 2020; 44:e21. PMID: 32117468.
      Citations:    Fields:    
    25. Cai A, Siddiqui M, Judd EK, Oparil S, Calhoun DA. Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertension. J Clin Hypertens (Greenwich). 2020 02; 22(2):167-173. PMID: 32049430.
      Citations: 1     Fields:    Translation:Humans
    26. Sharman JE, O'Brien E, Alpert B, Schutte AE, Delles C, Hecht Olsen M, Asmar R, Atkins N, Barbosa E, Calhoun D, Campbell NRC, Chalmers J, Benjamin I, Jennings G, Laurent S, Boutouyrie P, Lopez-Jaramillo P, McManus RJ, Mihailidou AS, Ordunez P, Padwal R, Palatini P, Parati G, Poulter N, Rakotz MK, Rosendorff C, Saladini F, Scuteri A, Sebba Barroso W, Cho MC, Sung KC, Townsend RR, Wang JG, Willum Hansen T, Wozniak G, Stergiou G. Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure. J Hypertens. 2020 01; 38(1):21-29. PMID: 31790375.
      Citations: 51     Fields:    Translation:Humans
    27. Siddiqui M, Judd EK, Dudenbostel T, Gupta P, Tomaszewski M, Patel P, Oparil S, Calhoun DA. Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension. Hypertension. 2020 02; 75(2):510-515. PMID: 31813346.
      Citations: 7     Fields:    Translation:Humans
    28. Buhnerkempe MG, Botchway A, Prakash V, Al-Akchar M, Nolasco Morales CE, Calhoun DA, Flack JM. Prevalence of refractory hypertension in the United States from 1999 to 2014. J Hypertens. 2019 09; 37(9):1797-1804. PMID: 31058798.
      Citations: 9     Fields:    Translation:Humans
    29. Siddiqui M, Judd EK, Dudenbostel T, Zhang B, Gupta P, Tomaszewski M, Patel P, Oparil S, Calhoun DA. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence. Hypertension. 2019 09; 74(3):652-659. PMID: 31327263.
      Citations: 7     Fields:    Translation:Humans
    30. Grassi G, Calhoun DA, Mancia G, Carey RM. Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines. Curr Hypertens Rep. 2019 07 18; 21(9):67. PMID: 31321564.
      Citations: 8     Fields:    Translation:Humans
    31. Flack JM, Calhoun D. The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence. Am J Hypertens. 2019 07 17; 32(8):705-708. PMID: 31314900.
      Citations:    Fields:    Translation:Humans
    32. Navarro-Soriano C, Mart?nez-Garc?a MA, Torres G, Barb? F, Caballero-Eraso C, Lloberes P, Cambriles TD, Somoza M, Masa JF, Gonz?lez M, Ma?as E, de la Pe?a M, Garc?a-R?o F, Montserrat JM, Muriel A, Oscullo G, Olmos LF, Garc?a-Ortega A, Calhoun D, Campos-Rodriguez F. Factors associated with the changes from a resistant to a refractory phenotype in hypertensive patients: a Pragmatic Longitudinal Study. Hypertens Res. 2019 11; 42(11):1708-1715. PMID: 31209397.
      Citations: 6     Fields:    Translation:Humans
    33. Navarro-Soriano C, Mart?nez-Garc?a MA, Torres G, Barb? F, Caballero-Eraso C, Lloberes P, Diaz Cambriles T, Somoza M, Masa JF, Gonz?lez M, Ma?as E, de la Pe?a M, Garc?a-R?o F, Montserrat JM, Muriel A, Oscullo G, Feced Olmos L, Garc?a-Ortega A, Calhoun D, Campos-Rodriguez F. Effect of continuous positive airway pressure in patients with true refractory hypertension and sleep apnea: a post-hoc intention-to-treat analysis of the HIPARCO randomized clinical trial. J Hypertens. 2019 06; 37(6):1269-1275. PMID: 30676482.
      Citations: 14     Fields:    Translation:Humans
    34. Calhoun DA. The Year in Clinical Hypertension From Other Pages. Am J Hypertens. 2019 04 22; 32(5):441-444. PMID: 31009040.
      Citations:    Fields:    Translation:Humans
    35. Acelajado MC, Hughes ZH, Oparil S, Calhoun DA. Treatment of Resistant and Refractory Hypertension. Circ Res. 2019 03 29; 124(7):1061-1070. PMID: 30920924.
      Citations: 62     Fields:    Translation:HumansAnimals
    36. Johnson DA, Thomas SJ, Abdalla M, Guo N, Yano Y, Rueschman M, Tanner RM, Mittleman MA, Calhoun DA, Wilson JG, Muntner P, Redline S. Association Between Sleep Apnea and Blood Pressure Control Among Blacks. Circulation. 2019 03 05; 139(10):1275-1284. PMID: 30586763.
      Citations: 29     Fields:    Translation:Humans
    37. Booth JN, Allen NB, Calhoun D, Carson AP, Deng L, Goff DC, Redden DT, Reis JP, Shimbo D, Shikany JM, Sidney S, Spring B, Lewis CE, Muntner P. Racial Differences in Maintaining Optimal Health Behaviors Into Middle Age. Am J Prev Med. 2019 03; 56(3):368-375. PMID: 30777156.
      Citations: 5     Fields:    Translation:Humans
    38. Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P. Prevalence of Apparent Treatment-Resistant Hypertension in the United States. Hypertension. 2019 02; 73(2):424-431. PMID: 30580690.
      Citations: 73     Fields:    Translation:Humans
    39. Butts B, Calhoun DA, Denney TS, Lloyd SG, Gupta H, Gaddam KK, Aban I, Oparil S, Sanders PW, Patel R, Collawn JF, Dell'Italia LJ. Plasma xanthine oxidase activity is related to increased sodium and left ventricular hypertrophy in resistant hypertension. Free Radic Biol Med. 2019 04; 134:343-349. PMID: 30695690.
      Citations: 6     Fields:    Translation:Humans
    40. Siddiqui M, Calhoun DA. Blood Pressure Measurement Challenges in Severely Obese Patients. Am J Hypertens. 2019 01 15; 32(2):139-140. PMID: 30383208.
      Citations: 2     Fields:    Translation:Humans
    41. Calhoun DA, Schiffrin EL, Flack JM. Resistant Hypertension: An Update. Am J Hypertens. 2019 01 01; 32(1):1-3. PMID: 30407514.
      Citations: 5     Fields:    Translation:Humans
    42. Siddiqui M, Judd EK, Jaeger BC, Bhatt H, Dudenbostel T, Zhang B, Edwards LJ, Oparil S, Calhoun DA. Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension. Hypertension. 2019 01; 73(1):132-141. PMID: 30571547.
      Citations: 17     Fields:    Translation:Humans
    43. Centor RM, Calhoun DA. Web Exclusive. Annals On Call - Primary Aldosteronism: How Often Are We Missing It? Ann Intern Med. 2018 Nov 20; 169(10):OC1. PMID: 30452580.
      Citations:    Fields:    
    44. Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018 11; 72(5):e53-e90. PMID: 30354828.
      Citations: 290     Fields:    Translation:Humans
    45. Smith SM, Gurka MJ, Calhoun DA, Gong Y, Pepine CJ, Cooper-DeHoff RM. Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD. Am J Med. 2018 12; 131(12):1463-1472.e7. PMID: 30142317.
      Citations: 6     Fields:    Translation:Humans
    46. Calhoun DA. Advances in resistant hypertension. Ann Transl Med. 2018 Aug; 6(15):294. PMID: 30211182.
      Citations:    
    47. Thomas SJ, Booth JN, Dai C, Li X, Allen N, Calhoun D, Carson AP, Gidding S, Lewis CE, Shikany JM, Shimbo D, Sidney S, Muntner P. Cumulative Incidence of Hypertension by 55?Years of Age in Blacks and Whites: The CARDIA Study. J Am Heart Assoc. 2018 07 11; 7(14). PMID: 29997132.
      Citations: 47     Fields:    Translation:Humans
    48. Velasco A, Siddiqui M, Kreps E, Kolakalapudi P, Dudenbostel T, Arora G, Judd EK, Prabhu SD, Lloyd SG, Oparil S, Calhoun DA. Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes. Hypertension. 2018 08; 72(2):343-349. PMID: 29866740.
      Citations: 12     Fields:    Translation:Humans
    49. Siddiqui M, Phillips RA, Bursztyn M, Sica D, Velasco A, Judd EK, Dudenbostel T, Lloyd SG, Oparil S, Calhoun DA. Case of Refractory Hypertension Controlled After Aortic and Mitral Valve Replacement and Coronary Artery Bypass Grafting. Hypertension. 2018 07; 72(1):3-9. PMID: 29735635.
      Citations:    Fields:    Translation:Humans
    50. Parikh V, Thaler E, Kato M, Gillespie MB, Nguyen S, Withrow K, Calhoun D, Soose R, Stevens D, Stevens S, Larsen C, Reddy M, Lakkireddy D. Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea. Heart Rhythm. 2018 08; 15(8):1165-1170. PMID: 29678782.
      Citations: 5     Fields:    Translation:Humans
    51. Calhoun DA. Fluid retention, aldosterone excess, and treatment of resistant hypertension. Lancet Diabetes Endocrinol. 2018 06; 6(6):431-433. PMID: 29655878.
      Citations: 3     Fields:    Translation:Humans
    52. Valaiyapathi B, Calhoun DA. Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome. Curr Hypertens Rep. 2018 03 19; 20(3):23. PMID: 29556729.
      Citations: 6     Fields:    Translation:Humans
    53. Calhoun DA. Medical Versus Surgical Treatment of Primary Aldosteronism. Hypertension. 2018 04; 71(4):566-568. PMID: 29483223.
      Citations: 4     Fields:    Translation:Humans
    54. Irvin MR, Booth JN, Sims M, Bress AP, Abdalla M, Shimbo D, Calhoun DA, Muntner P. The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study. J Clin Hypertens (Greenwich). 2018 03; 20(3):438-446. PMID: 29436105.
      Citations: 6     Fields:    Translation:Humans
    55. Cai A, Calhoun DA. Antihypertensive Medications and Falls in the Elderly. Am J Hypertens. 2018 02 09; 31(3):281-283. PMID: 29186306.
      Citations: 5     Fields:    Translation:Humans
    56. Flack JM, Calhoun D, Schiffrin EL. The New ACC/AHA Hypertension Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Am J Hypertens. 2018 01 12; 31(2):133-135. PMID: 29228096.
      Citations: 25     Fields:    Translation:Humans
    57. Armario P, Calhoun DA, Oliveras A, Blanch P, Vinyoles E, Banegas JR, Gorostidi M, Segura J, Ruilope LM, Dudenbostel T, de la Sierra A. Prevalence and Clinical Characteristics of Refractory Hypertension. J Am Heart Assoc. 2017 Dec 07; 6(12). PMID: 29217663.
      Citations: 17     Fields:    Translation:Humans
    58. Calhoun DA, Grassi G. True versus pseudoresistant hypertension. J Hypertens. 2017 12; 35(12):2367-2368. PMID: 29095227.
      Citations:    Fields:    Translation:Humans
    59. Eirin A, Saad A, Woollard JR, Juncos LA, Calhoun DA, Tang H, Lerman A, Textor SC, Lerman LO. Glomerular Hyperfiltration in Obese African American Hypertensive Patients Is Associated With Elevated Urinary Mitochondrial-DNA Copy Number. Am J Hypertens. 2017 Nov 01; 30(11):1112-1119. PMID: 28641368.
      Citations: 17     Fields:    Translation:Humans
    60. Dudenbostel T, Siddiqui M, Gharpure N, Calhoun DA. Refractory versus resistant hypertension: Novel distinctive phenotypes. J Nat Sci. 2017 Sep; 3(9). PMID: 29034321.
      Citations:    
    61. Tolosa JN, Calhoun DA. Maternal and neonatal demographics of macrosomic infants admitted to the neonatal intensive care unit. J Perinatol. 2017 12; 37(12):1292-1296. PMID: 28837137.
      Citations: 2     Fields:    Translation:Humans
    62. Siddiqui M, Judd EK, Oparil S, Calhoun DA. White-Coat Effect Is Uncommon in Patients With Refractory Hypertension. Hypertension. 2017 09; 70(3):645-651. PMID: 28696223.
      Citations: 13     Fields:    Translation:Humans
    63. Calhoun DA. Sleep disorders and hypertension risk. J Hum Hypertens. 2017 06; 31(6):371-372. PMID: 28465616.
      Citations: 4     Fields:    Translation:Humans
    64. Cai A, Calhoun DA. Resistant Hypertension: An Update of Experimental and Clinical Findings. Hypertension. 2017 07; 70(1):5-9. PMID: 28507173.
      Citations: 19     Fields:    Translation:Humans
    65. Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, Calhoun DA. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension. Am J Hypertens. 2017 May 01; 30(5):518-523. PMID: 28180242.
      Citations:    Fields:    Translation:Humans
    66. Wolley MJ, Pimenta E, Calhoun D, Gordon RD, Cowley D, Stowasser M. Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea. J Hum Hypertens. 2017 09; 31(9):561-567. PMID: 28382959.
      Citations: 14     Fields:    Translation:Humans
    67. Ghazi L, Oparil S, Calhoun DA, Lin CP, Dudenbostel T. Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant. Hypertension. 2017 05; 69(5):827-835. PMID: 28348010.
      Citations: 3     Fields:    Translation:Humans
    68. Thomas SJ, Booth JN, Bromfield SG, Seals SR, Spruill TM, Ogedegbe G, Kidambi S, Shimbo D, Calhoun D, Muntner P. Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study. J Am Soc Hypertens. 2017 Apr; 11(4):204-212.e5. PMID: 28285829.
      Citations: 20     Fields:    Translation:Humans
    69. Vemulapalli S, Deng L, Patel MR, Kilgore ML, Jones WS, Curtis LH, Irvin MR, Svetkey LP, Shimbo D, Calhoun DA, Muntner P. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension. Am Heart J. 2017 Apr; 186:29-39. PMID: 28454830.
      Citations: 2     Fields:    Translation:Humans
    70. Siddiqui M, Calhoun DA. Refractory versus resistant hypertension. Curr Opin Nephrol Hypertens. 2017 01; 26(1):14-19. PMID: 27798457.
      Citations: 11     Fields:    Translation:Humans
    71. Schiffrin EL, Calhoun DA, Flack JM, Ito S, Webb RC. Update From the Editors to Our Readers. Am J Hypertens. 2017 01; 30(1):1-2. PMID: 27940428.
      Citations:    Fields:    
    72. Thomas SJ, Calhoun D. Sleep, insomnia, and hypertension: current findings and future directions. J Am Soc Hypertens. 2017 02; 11(2):122-129. PMID: 28109722.
      Citations: 47     Fields:    Translation:Humans
    73. Ghazi L, Dudenbostel T, Xing D, Ejem D, Turner-Henson A, Joiner CI, Affuso O, Azuero A, Oparil S, Calhoun DA, Rice M, Hage FG. Assessment of vascular function in low socioeconomic status preschool children: a pilot study. J Am Soc Hypertens. 2017 02; 11(2):101-109. PMID: 28063813.
      Citations: 2     Fields:    Translation:Humans
    74. Dudenbostel T, Calhoun DA. Effects of Spironolactone and Renal Denervation Treatment on Blood Pressure and Its Variability-Different Aspects of Hypertension Treatment. Am J Hypertens. 2017 01; 30(1):12-15. PMID: 27838625.
      Citations:    Fields:    Translation:Humans
    75. Bangalore S, Davis BR, Cushman WC, Pressel SL, Muntner PM, Calhoun DA, Kostis JB, Whelton PK, Probstfield JL, Rahman M, Black HR. Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT. Am J Med. 2017 Apr; 130(4):439-448.e9. PMID: 27984005.
      Citations: 7     Fields:    Translation:Humans
    76. Biaggioni I, Calhoun DA. Sympathetic Activity, Hypertension, and The Importance of a Good Night's Sleep. Hypertension. 2016 12; 68(6):1338-1339. PMID: 27698060.
      Citations:    Fields:    Translation:Humans
    77. Bhatt H, Ghazi L, Calhoun D, Oparil S. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out? Curr Cardiol Rep. 2016 10; 18(10):98. PMID: 27566331.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    78. Calhoun DA. Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance. Korean Circ J. 2016 Sep; 46(5):593-600. PMID: 27721847.
      Citations:    
    79. Dudenbostel T, Calhoun DA. Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension. Am J Hypertens. 2017 Feb; 30(2):103-109. PMID: 27609503.
      Citations: 23     Fields:    Translation:Humans
    80. Calhoun DA. Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension. J Hypertens. 2016 09; 34(9):1701-3. PMID: 27488549.
      Citations: 1     Fields:    Translation:Humans
    81. Calhoun DA. Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension. Circulation. 2016 09 20; 134(12):858-60. PMID: 27576779.
      Citations: 2     Fields:    Translation:Humans
    82. Saddekni MB, Saag KG, Dudenbostel T, Oparil S, Calhoun DA, Sattui SE, Feig DI, Muntner P, Redden DT, Foster PJ, Rahn EJ, Biggers SR, Li P, Gaffo AL. The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. Contemp Clin Trials. 2016 09; 50:238-44. PMID: 27587282.
      Citations: 3     Fields:    Translation:Humans
    83. Dudenbostel T, Ghazi L, Liu M, Li P, Oparil S, Calhoun DA. Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension. Hypertension. 2016 10; 68(4):995-1003. PMID: 27528066.
      Citations: 22     Fields:    Translation:Humans
    84. Bhandari SK, Shi J, Molnar MZ, Rasgon SA, Derose SF, Kovesdy CP, Calhoun DA, Kalantar-Zadeh K, Jacobsen SJ, Sim JJ. Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension. Respirology. 2016 11; 21(8):1486-1492. PMID: 27427469.
      Citations: 4     Fields:    Translation:Humans
    85. Schiffrin EL, Calhoun DA, Flack JM. Do We Need a New Definition of Hypertension After SPRINT? Am J Hypertens. 2016 10; 29(10):1127-9. PMID: 27334926.
      Citations: 7     Fields:    Translation:Humans
    86. Battaglin WA, Smalling KL, Anderson C, Calhoun D, Chestnut T, Muths E. Potential interactions among disease, pesticides, water quality and adjacent land cover in amphibian habitats in the United States. Sci Total Environ. 2016 Oct 01; 566-567:320-332. PMID: 27232962.
      Citations: 15     Fields:    Translation:AnimalsPHPublic Health
    87. Ghazi L, Dudenbostel T, Lin CP, Oparil S, Calhoun DA. Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status. J Hypertens. 2016 May; 34(5):1005-10. PMID: 26886564.
      Citations: 8     Fields:    Translation:Humans
    88. Dudenbostel T, Siddiqui M, Oparil S, Calhoun DA. Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure. Hypertension. 2016 06; 67(6):1085-92. PMID: 27091893.
      Citations: 26     Fields:    Translation:Humans
    89. Corr?a NB, de Faria AP, Ritter AM, Sabbatini AR, Almeida A, Brunelli V, Calhoun DA, Moreno H, Modolo R. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension. J Am Soc Hypertens. 2016 06; 10(6):510-516.e1. PMID: 27161936.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    90. Pimenta E, Calhoun DA. Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension? Curr Hypertens Rep. 2016 Apr; 18(4):25. PMID: 26949263.
      Citations: 3     Fields:    Translation:Humans
    91. Bhatt H, Siddiqui M, Judd E, Oparil S, Calhoun D. Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. J Am Soc Hypertens. 2016 06; 10(6):493-9. PMID: 27129931.
      Citations: 19     Fields:    Translation:Humans
    92. Muntner P, Becker RC, Calhoun D, Chen D, Cowley AW, Flynn JT, Grobe JL, Kidambi S, Kotchen TA, Lackland DT, Leslie KK, Li Y, Liang M, Lloyd A, Mattson DL, Mendizabal B, Mitsnefes M, Nair A, Pierce GL, Pollock JS, Safford MM, Santillan MK, Sigmund CD, Thomas SJ, Urbina EM. Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. Hypertension. 2016 Apr; 67(4):674-80. PMID: 26902490.
      Citations: 3     Fields:    Translation:Humans
    93. Krzywanski DM, Moellering DR, Westbrook DG, Dunham-Snary KJ, Brown J, Bray AW, Feeley KP, Sammy MJ, Smith MR, Schurr TG, Vita JA, Ambalavanan N, Calhoun D, Dell'Italia L, Ballinger SW. Endothelial Cell Bioenergetics and Mitochondrial DNA Damage Differ in Humans Having African or West Eurasian Maternal Ancestry. Circ Cardiovasc Genet. 2016 Feb; 9(1):26-36. PMID: 26787433.
      Citations: 20     Fields:    Translation:HumansCells
    94. Schiffrin EL, Calhoun DA, Flack JM, Ito S, Webb RC. A Message From the New Editorial Team at the American Journal of Hypertension. Am J Hypertens. 2016 Jan; 29(1):1. PMID: 26658829.
      Citations:    Fields:    Translation:Humans
    95. Judd E, Calhoun DA. Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step Beyond Observed Risk. Hypertension. 2016 Feb; 67(2):275-7. PMID: 26711736.
      Citations: 2     Fields:    Translation:Humans
    96. Schiffrin EL, Calhoun DA, Flack JM. SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a Price. Am J Hypertens. 2016 Jan; 29(1):2-4. PMID: 26597221.
      Citations: 9     Fields:    Translation:Humans
    97. Ellis AC, Patterson M, Dudenbostel T, Calhoun D, Gower B. Effects of 6-month supplementation with ?-hydroxy-?-methylbutyrate, glutamine and arginine on vascular endothelial function of older adults. Eur J Clin Nutr. 2016 Feb; 70(2):269-73. PMID: 26306566.
      Citations: 9     Fields:    Translation:Humans
    98. Siddiqui M, Dudenbostel T, Calhoun DA. Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure. Can J Cardiol. 2016 05; 32(5):603-6. PMID: 26514749.
      Citations: 21     Fields:    Translation:Humans
    99. Calhoun DA. Editorial comment: change in leadership. J Hum Hypertens. 2015 Jun; 29(6):339. PMID: 25943036.
      Citations:    Fields:    Translation:Humans
    100. Dudenbostel T, Acelajado MC, Pisoni R, Li P, Oparil S, Calhoun DA. Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure. Hypertension. 2015 Jul; 66(1):126-33. PMID: 25987662.
      Citations: 54     Fields:    Translation:Humans
    101. Sim JJ, Bhandari SK, Shi J, Reynolds K, Calhoun DA, Kalantar-Zadeh K, Jacobsen SJ. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015 Sep; 88(3):622-32. PMID: 25945406.
      Citations: 79     Fields:    Translation:Humans
    102. Breaux-Shropshire TL, Whitt L, Oster RA, Lewis D, Shropshire TS, Calhoun DA. Results of an Academic, Health Care Worksite Weight Loss Contest for Southeastern Americans: Scale Back Alabama 2011-2013. Workplace Health Saf. 2015 Apr; 63(4):165-9. PMID: 26081473.
      Citations:    Fields:    Translation:Humans
    103. Yano Y, Ning H, Muntner P, Reis JP, Calhoun DA, Viera AJ, Levine DA, Jacobs DR, Shimbo D, Liu K, Greenland P, Lloyd-Jones D. Nocturnal Blood Pressure in Young Adults and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Hypertens. 2015 Oct; 28(10):1240-7. PMID: 25783740.
      Citations: 9     Fields:    Translation:Humans
    104. Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens. 2015 Dec; 29(12):705-12. PMID: 25761667.
      Citations: 91     Fields:    Translation:Humans
    105. Howard VJ, Tanner RM, Anderson A, Irvin MR, Calhoun DA, Lackland DT, Oparil S, Muntner P. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack. Am J Med. 2015 Jul; 128(7):707-14.e2. PMID: 25770032.
      Citations: 18     Fields:    Translation:Humans
    106. Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis. 2015 Mar; 22(2):116-22. PMID: 25704348.
      Citations: 59     Fields:    Translation:Humans
    107. Biederman RW, Young AA, Doyle M, Devereux RB, Kortright E, Perry G, Bella JN, Oparil S, Calhoun D, Pohost GM, Dell'Italia LJ. Regional Heterogeneity in 3D Myocardial Shortening in Hypertensive Left Ventricular Hypertrophy: A Cardiovascular CMR Tagging Substudy to the Life Study. J Biomed Sci Eng. 2015 Mar 01; 8(3):213-225. PMID: 27011783.
      Citations:    
    108. Meghdari M, Gao N, Abdullahi A, Stokes E, Calhoun DH. Carboxyl-terminal truncations alter the activity of the human a-galactosidase A. PLoS One. 2015; 10(2):e0118341. PMID: 25719393.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    109. Nikolova D, Rumley S, Calhoun D, Li Q, Hendry R, Samadi P, Bergman K. Scaling silicon photonic switch fabrics for data center interconnection networks. Opt Express. 2015 Jan 26; 23(2):1159-75. PMID: 25835876.
      Citations: 4     Fields:    
    110. Ashraf AP, Alvarez JA, Dudenbostel T, Calhoun D, Griffin R, Wang X, Hanks LJ, Gower BA. Associations between vascular health indices and serum total, free and bioavailable 25-hydroxyvitamin D in adolescents. PLoS One. 2014; 9(12):e114689. PMID: 25479358.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    111. Muntner P, Lewis CE, Diaz KM, Carson AP, Kim Y, Calhoun D, Yano Y, Viera AJ, Shimbo D. Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Hypertens. 2015 May; 28(5):640-8. PMID: 25376639.
      Citations: 59     Fields:    Translation:Humans
    112. Schiros CG, Desai RV, Venkatesh BA, Gaddam KK, Agarwal S, Lloyd SG, Calhoun DA, Denney TS, Dell'italia LJ, Gupta H. Left ventricular torsion shear angle volume analysis in patients with hypertension: a global approach for LV diastolic function. J Cardiovasc Magn Reson. 2014 Sep 26; 16:70. PMID: 25316384.
      Citations: 9     Fields:    Translation:Humans
    113. Gupta A, Schiros CG, Gaddam KK, Aban I, Denney TS, Lloyd SG, Oparil S, Dell'Italia LJ, Calhoun DA, Gupta H. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy. J Hum Hypertens. 2015 Apr; 29(4):241-6. PMID: 25231508.
      Citations: 12     Fields:    Translation:Humans
    114. Yamal JM, Oparil S, Davis BR, Alderman MH, Calhoun DA, Cushman WC, Fendley HF, Franklin SS, Habib GB, Pressel SL, Probstfield JL, Sastrasinh S. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. J Am Soc Hypertens. 2014 Nov; 8(11):808-19. PMID: 25455006.
      Citations: 9     Fields:    Translation:Humans
    115. Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2014 Nov; 64(5):1012-21. PMID: 25259745.
      Citations: 86     Fields:    Translation:Humans
    116. Modolo R, de Faria AP, Paganelli MO, Sabbatini AR, Barbaro NR, Nascimento BB, Ramos CD, Fontana V, Calhoun DA, Moreno H. Predictors of silent myocardial ischemia in resistant hypertensive patients. Am J Hypertens. 2015 Feb; 28(2):200-7. PMID: 25063735.
      Citations: 2     Fields:    Translation:Humans
    117. White WB, Turner JR, Sica DA, Bisognano JD, Calhoun DA, Townsend RR, Aronow HD, Bhatt DL, Bakris GL. Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013. J Am Soc Hypertens. 2014 Oct; 8(10):743-57. PMID: 25418497.
      Citations: 21     Fields:    Translation:Humans
    118. Breaux-Shropshire TL, Whitt L, Griffin RL, Shropshire AT, Calhoun DA. Characterizing workers participating in a worksite wellness health screening program using blood pressure control, self-monitoring, medication adherence, depression, and exercise. Workplace Health Saf. 2014 Jul; 62(7):292-300. PMID: 25000548.
      Citations:    Fields:    Translation:HumansPHPublic Health
    119. Ferdinand KC, White WB, Calhoun DA, Lonn EM, Sager PT, Brunelle R, Jiang HH, Threlkeld RJ, Robertson KE, Geiger MJ. Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus. Hypertension. 2014 Oct; 64(4):731-7. PMID: 24980665.
      Citations: 51     Fields:    Translation:Humans
    120. Diaz KM, Booth JN, Calhoun DA, Irvin MR, Howard G, Safford MM, Muntner P, Shimbo D. Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study. Hypertension. 2014 Sep; 64(3):465-71. PMID: 24914189.
      Citations: 35     Fields:    Translation:Humans
    121. Calhoun DA, Booth JN, Oparil S, Irvin MR, Shimbo D, Lackland DT, Howard G, Safford MM, Muntner P. Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension? Hypertension. 2014 Apr; 63(4):e84. PMID: 24757730.
      Citations:    Fields:    Translation:HumansPHPublic Health
    122. Irvin MR, Booth JN, Shimbo D, Lackland DT, Oparil S, Howard G, Safford MM, Muntner P, Calhoun DA. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. J Am Soc Hypertens. 2014 Jun; 8(6):405-13. PMID: 24952653.
      Citations: 63     Fields:    Translation:Humans
    123. Judd E, Calhoun DA. Management of Resistant Hypertension: Do Not Give Up on Medication. Nephrol Self Assess Program. 2014 Mar; 13(2):57-63. PMID: 25642153.
      Citations:    
    124. Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, Calhoun DA. Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity. Hypertension. 2014 Mar; 63(3):e17-8. PMID: 24491391.
      Citations:    Fields:    Translation:Humans
    125. Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014 Aug; 28(8):463-8. PMID: 24430707.
      Citations: 96     Fields:    Translation:Humans
    126. de la Sierra A, Calhoun DA, Vinyoles E, Banegas JR, de la Cruz JJ, Gorostidi M, Segura J, Ruilope LM. Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance. J Hum Hypertens. 2014 Jul; 28(7):416-20. PMID: 24401954.
      Citations: 8     Fields:    Translation:Humans
    127. Tanner RM, Calhoun DA, Bell EK, Bowling CB, Guti?rrez OM, Irvin MR, Lackland DT, Oparil S, McClellan W, Warnock DG, Muntner P. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis. 2014 May; 63(5):781-8. PMID: 24388119.
      Citations: 22     Fields:    Translation:Humans
    128. Judd EK, Calhoun DA, Warnock DG. Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels. Semin Nephrol. 2014; 34(5):532-9. PMID: 25416662.
      Citations: 9     Fields:    Translation:Humans
    129. Calhoun DA, Booth JN, Oparil S, Irvin MR, Shimbo D, Lackland DT, Howard G, Safford MM, Muntner P. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014 Mar; 63(3):451-8. PMID: 24324035.
      Citations: 67     Fields:    Translation:HumansPHPublic Health
    130. Santos RC, de Faria AP, Barbaro NR, Modolo R, Ferreira-Melo SE, Matos-Souza JR, Coelho OR, Yugar-Toledo JC, Fontana V, Calhoun D, Moreno H. Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension. Eur J Clin Pharmacol. 2014 Feb; 70(2):147-54. PMID: 24271647.
      Citations: 7     Fields:    Translation:Humans
    131. Kumar N, Calhoun DA, Dudenbostel T. Management of patients with resistant hypertension: current treatment options. Integr Blood Press Control. 2013 Oct 22; 6:139-51. PMID: 24231917.
      Citations:    
    132. Sim JJ, Bhandari SK, Shi J, Liu IL, Calhoun DA, McGlynn EA, Kalantar-Zadeh K, Jacobsen SJ. Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. Mayo Clin Proc. 2013 Oct; 88(10):1099-107. PMID: 24079679.
      Citations: 83     Fields:    Translation:Humans
    133. Calhoun DA. Apparent and true resistant hypertension: why not the same? J Am Soc Hypertens. 2013 Nov-Dec; 7(6):509-11. PMID: 24035315.
      Citations: 8     Fields:    Translation:Humans
    134. Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, Calhoun DA. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013 Oct; 62(4):691-7. PMID: 23918752.
      Citations: 60     Fields:    Translation:Humans
    135. Flores FX, Ojeda FJ, Calhoun DA. Bartter syndrome: presentation in an extremely premature neonate. J Perinatol. 2013 Aug; 33(8):661-2. PMID: 23897314.
      Citations: 1     Fields:    Translation:Humans
    136. Pimenta E, Calhoun DA. Response. Chest. 2013 Aug; 144(2):720. PMID: 23918137.
      Citations:    Fields:    Translation:Humans
    137. Tanner RM, Calhoun DA, Bell EK, Bowling CB, Guti?rrez OM, Irvin MR, Lackland DT, Oparil S, Warnock D, Muntner P. Prevalence of apparent treatment-resistant hypertension among individuals with CKD. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1583-90. PMID: 23868902.
      Citations: 50     Fields:    Translation:Humans
    138. Calhoun DA, Lacourci?re Y, Crikelair N, Jia Y, Glazer RD. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension. Curr Med Res Opin. 2013 Aug; 29(8):901-10. PMID: 23721363.
      Citations: 9     Fields:    Translation:Humans
    139. Eirin A, Zhu XY, Woollard JR, Herrmann SM, Gloviczki ML, Saad A, Juncos LA, Calhoun DA, Rule AD, Lerman A, Textor SC, Lerman LO. Increased circulating inflammatory endothelial cells in blacks with essential hypertension. Hypertension. 2013 Sep; 62(3):585-91. PMID: 23798347.
      Citations: 14     Fields:    Translation:HumansCells
    140. Guichard JL, Clark D, Calhoun DA, Ahmed MI. Aldosterone receptor antagonists: current perspectives and therapies. Vasc Health Risk Manag. 2013; 9:321-31. PMID: 23836977.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    141. Pimenta E, Stowasser M, Gordon RD, Harding SM, Batlouni M, Zhang B, Oparil S, Calhoun DA. Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. Chest. 2013 Apr; 143(4):978-983. PMID: 23288434.
      Citations: 33     Fields:    Translation:Humans
    142. Shimbo D, Levitan EB, Booth JN, Calhoun DA, Judd SE, Lackland DT, Safford MM, Oparil S, Muntner P. The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Hypertens. 2013 Feb; 31(2):370-6. PMID: 23303356.
      Citations: 29     Fields:    Translation:Humans
    143. Moreno H, Calhoun DA. True resistant hypertension: definition and prevalence. J Hypertens. 2012 Nov; 30(11):2241-2; author reply 2242-2243. PMID: 23052050.
      Citations:    Fields:    Translation:Humans
    144. Calhoun DA. Hyperaldosteronism as a common cause of resistant hypertension. Annu Rev Med. 2013; 64:233-47. PMID: 23092384.
      Citations: 29     Fields:    Translation:Humans
    145. Ashraf AP, Fisher G, Alvarez J, Dudenbostel T, Calhoun DA, Szalai AJ, Gower BA. Associations of C-Reactive Protein to Indices of Vascular Health and the Influence of Serum 25(OH)D Status in Healthy Adults. J Nutr Metab. 2012; 2012:475975. PMID: 23029606.
      Citations:    
    146. Gorelick PB, Nyenhuis D, Materson BJ, Calhoun DA, Elliott WJ, Phillips RA, Taler SJ, Townsend RR. Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function. J Am Soc Hypertens. 2012 Sep-Oct; 6(5):309-15. PMID: 22995799.
      Citations: 31     Fields:    Translation:Humans
    147. Irvin MR, Shimbo D, Mann DM, Reynolds K, Krousel-Wood M, Limdi NA, Lackland DT, Calhoun DA, Oparil S, Muntner P. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension. J Clin Hypertens (Greenwich). 2012 Oct; 14(10):694-700. PMID: 23031147.
      Citations: 31     Fields:    Translation:Humans
    148. Alessi A, Brand?o AA, Coca A, Cordeiro AC, Cordeiro A, Nogueira AR, Di?genes de Magalh?es F, Feitosa A, Amodeo C, Saad Rodrigues CI, Rodrigues C, Calhoun DA, Calhoun D, Barbosa Coelho E, Barbosa E, Pimenta E, Muxfeldt E, Consolin-Colombo FM, Consolin-Colombo F, Salles G, Rosito G, Moreno H, Martin JF, Yugar JC, Aparecido Bortolotto L, Bortolotto L, Naz?rio Scala LC, Scala LC, Gon?alves de Sousa M, Souza Md, Gomes MA, Malachias MB, Gus M, Passarelli O, Jardim PC, Toscano PR, S?nchez RA, Sanchez R, Dischinger Miranda R, Miranda RD, P?voa R, Barroso WK. First Brazilian position on resistant hypertension. Arq Bras Cardiol. 2012 Jul; 99(1):576-85. PMID: 22948302.
      Citations: 15     Fields:    Translation:Humans
    149. Alvarez JA, Gower BA, Calhoun DA, Judd SE, Dong Y, Dudenbostel T, Scholl J, Ashraf AP. Serum 25-hydroxyvitamin D and Ethnic Differences in Arterial Stiffness and Endothelial Function. J Clin Med Res. 2012 Jun; 4(3):197-205. PMID: 22719806.
      Citations:    
    150. Pimenta E, Calhoun DA. Hypertensive crisis: forget the numbers. J Hypertens. 2012 May; 30(5):882-3. PMID: 22495131.
      Citations: 2     Fields:    Translation:Humans
    151. Clark D, Ahmed MI, Calhoun DA. Resistant hypertension and aldosterone: an update. Can J Cardiol. 2012 May; 28(3):318-25. PMID: 22521297.
      Citations: 23     Fields:    Translation:Humans
    152. Alderman MH, Piller LB, Ford CE, Probstfield JL, Oparil S, Cushman WC, Einhorn PT, Franklin SS, Papademetriou V, Ong ST, Eckfeldt JH, Furberg CD, Calhoun DA, Davis BR. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2012 May; 59(5):926-33. PMID: 22431578.
      Citations: 26     Fields:    Translation:Humans
    153. Ahmed MI, Desai RV, Gaddam KK, Venkatesh BA, Agarwal S, Inusah S, Lloyd SG, Denney TS, Calhoun D, Dell'italia LJ, Gupta H. Relation of torsion and myocardial strains to LV ejection fraction in hypertension. JACC Cardiovasc Imaging. 2012 Mar; 5(3):273-81. PMID: 22421172.
      Citations: 29     Fields:    Translation:Humans
    154. Pimenta E, Calhoun DA. Resistant hypertension: incidence, prevalence, and prognosis. Circulation. 2012 Apr 03; 125(13):1594-6. PMID: 22379111.
      Citations: 72     Fields:    Translation:Humans
    155. Clark D, Guichard JL, Calhoun DA, Ahmed MI. Recent advancements in the treatment of resistant hypertension. Postgrad Med. 2012 Jan; 124(1):67-73. PMID: 22314116.
      Citations: 4     Fields:    Translation:Humans
    156. Judd E, Calhoun DA. Hypertension and orthostatic hypotension in older patients. J Hypertens. 2012 Jan; 30(1):38-9. PMID: 22157584.
      Citations: 2     Fields:    Translation:Humans
    157. Textor SC, Gloviczki ML, Flessner MF, Calhoun DA, Glockner J, Grande JP, McKusick MA, Cha SS, Lerman LO. Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites. Am J Kidney Dis. 2012 Feb; 59(2):229-37. PMID: 22130642.
      Citations: 20     Fields:    Translation:Humans
    158. Acelajado MC, Pisoni R, Dudenbostel T, Dell'Italia LJ, Cartmill F, Zhang B, Cofield SS, Oparil S, Calhoun DA. Refractory hypertension: definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich). 2012 Jan; 14(1):7-12. PMID: 22235818.
      Citations: 73     Fields:    Translation:Humans
    159. Acelajado MC, Pisoni R, Dudenbostel T, Oparil S, Calhoun DA, Glasser SP. Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. J Am Soc Hypertens. 2012 Jan-Feb; 6(1):66-72. PMID: 22024668.
      Citations: 15     Fields:    Translation:Humans
    160. Calhoun DA, White WB, Krum H, Guo W, Bermann G, Trapani A, Lefkowitz MP, M?nard J. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation. 2011 Nov 01; 124(18):1945-55. PMID: 21986283.
      Citations: 60     Fields:    Translation:HumansCTClinical Trials
    161. Epstein M, Calhoun DA. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich). 2011 Sep; 13(9):644-8. PMID: 21896143.
      Citations: 24     Fields:    Translation:Humans
    162. Sim JJ, Yan EH, Liu IL, Rasgon SA, Kalantar-Zadeh K, Calhoun DA, Derose SF. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population. J Hypertens. 2011 Aug; 29(8):1553-9. PMID: 21720263.
      Citations: 18     Fields:    Translation:Humans
    163. Pisoni R, Acelajado MC, Cartmill FR, Dudenbostel T, Dell'Italia LJ, Cofield SS, Oparil S, Calhoun DA. Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease. J Hum Hypertens. 2012 Aug; 26(8):502-6. PMID: 21677673.
      Citations: 9     Fields:    Translation:Humans
    164. Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens. 2012 May; 26(5):281-7. PMID: 21654850.
      Citations: 58     Fields:    Translation:HumansCells
    165. Quinaglia T, Martins LC, Figueiredo VN, Santos RC, Yugar-Toledo JC, Martin JF, Demacq C, Pimenta E, Calhoun DA, Moreno H. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension. J Hum Hypertens. 2011 Nov; 25(11):656-64. PMID: 21544090.
      Citations: 20     Fields:    Translation:Humans
    166. Ahmed MI, Calhoun DA. Resistant hypertension: bad and getting worse. Hypertension. 2011 Jun; 57(6):1045-6. PMID: 21502566.
      Citations: 3     Fields:    Translation:Humans
    167. Yugar-Toledo JC, Martin JF, Krieger JE, Pereira AC, Demacq C, Coelho OR, Pimenta E, Calhoun DA, J?nior HM. Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes. DNA Cell Biol. 2011 Aug; 30(8):555-64. PMID: 21438754.
      Citations: 21     Fields:    Translation:Humans
    168. Lacourci?re Y, Crikelair N, Glazer RD, Yen J, Calhoun DA. 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension. J Hum Hypertens. 2011 Oct; 25(10):615-22. PMID: 21248785.
      Citations: 18     Fields:    Translation:Humans
    169. Acelajado MC, Calhoun DA. Aldosteronism and resistant hypertension. Int J Hypertens. 2011 Jan 20; 2011:837817. PMID: 21331160.
      Citations:    
    170. Levine DA, Calhoun DA, Prineas RJ, Cushman M, Howard VJ, Howard G. Moderate waist circumference and hypertension prevalence: the REGARDS Study. Am J Hypertens. 2011 Apr; 24(4):482-8. PMID: 21233800.
      Citations: 16     Fields:    Translation:Humans
    171. Levine DA, Lewis CE, Williams OD, Safford MM, Liu K, Calhoun DA, Kim Y, Jacobs DR, Kiefe CI. Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study. Hypertension. 2011 Jan; 57(1):39-47. PMID: 21135358.
      Citations: 37     Fields:    Translation:Humans
    172. Ahmed MI, Calhoun DA. Apparent resistant hypertension and medication adherence. Hypertens Res. 2011 Jan; 34(1):41-2. PMID: 21107331.
      Citations:    Fields:    Translation:Humans
    173. Acelajado MC, Calhoun DA. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment. Cardiol Clin. 2010 Nov; 28(4):639-54. PMID: 20937447.
      Citations: 17     Fields:    Translation:Humans
    174. Pimenta E, Calhoun DA. Treatment of resistant hypertension. J Hypertens. 2010 Nov; 28(11):2194-5. PMID: 20948392.
      Citations: 5     Fields:    Translation:Humans
    175. Martins LC, Figueiredo VN, Quinaglia T, Boer-Martins L, Yugar-Toledo JC, Martin JF, Demacq C, Pimenta E, Calhoun DA, Moreno H. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness. J Hum Hypertens. 2011 Sep; 25(9):532-8. PMID: 20927128.
      Citations: 29     Fields:    Translation:Humans
    176. Acelajado MC, Pimenta E, Calhoun DA. Salt and aldosterone: a concert of bad effects. Hypertension. 2010 Nov; 56(5):804-5. PMID: 20921423.
      Citations: 5     Fields:    Translation:Humans
    177. Gonzaga CC, Gaddam KK, Ahmed MI, Pimenta E, Thomas SJ, Harding SM, Oparil S, Cofield SS, Calhoun DA. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med. 2010 Aug 15; 6(4):363-8. PMID: 20726285.
      Citations: 65     Fields:    Translation:Humans
    178. Calhoun DA, Sharma K. The role of aldosteronism in causing obesity-related cardiovascular risk. Cardiol Clin. 2010 Aug; 28(3):517-27. PMID: 20621254.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    179. Calhoun DA, Harding SM. Sleep and hypertension. Chest. 2010 Aug; 138(2):434-43. PMID: 20682533.
      Citations: 107     Fields:    Translation:Humans
    180. Calhoun DA. Obstructive sleep apnea and hypertension. Curr Hypertens Rep. 2010 Jun; 12(3):189-95. PMID: 20424946.
      Citations: 30     Fields:    Translation:Humans
    181. Gaddam K, Corros C, Pimenta E, Ahmed M, Denney T, Aban I, Inusah S, Gupta H, Lloyd SG, Oparil S, Husain A, Dell'Italia LJ, Calhoun DA. Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study. Hypertension. 2010 May; 55(5):1137-42. PMID: 20351345.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    182. Calhoun DA, Crikelair NA, Yen J, Glazer RD. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety. Adv Ther. 2009 Nov; 26(11):1012-23. PMID: 20024680.
      Citations: 10     Fields:    Translation:Humans
    183. Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, Calhoun DA. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010 Aug; 24(8):532-7. PMID: 20016520.
      Citations: 101     Fields:    Translation:HumansCTClinical Trials
    184. Zappe DH, Palmer BF, Calhoun DA, Purkayastha D, Samuel R, Jamerson KA. Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension. J Hum Hypertens. 2010 Jul; 24(7):483-91. PMID: 20010618.
      Citations:    Fields:    Translation:Humans
    185. Acelajado MC, Calhoun DA, Oparil S. Reduction of blood pressure in patients with treatment-resistant hypertension. Expert Opin Pharmacother. 2009 Dec; 10(18):2959-71. PMID: 19925047.
      Citations: 1     Fields:    Translation:Humans
    186. Czarina Acelajado M, Calhoun DA. Treatment of resistant hypertension. Minerva Cardioangiol. 2009 Dec; 57(6):787-812. PMID: 19942848.
      Citations: 2     Fields:    Translation:Humans
    187. Pisoni R, Ahmed MI, Calhoun DA. Characterization and treatment of resistant hypertension. Curr Cardiol Rep. 2009 Nov; 11(6):407-13. PMID: 19863864.
      Citations: 13     Fields:    Translation:Humans
    188. Ahmed MI, Pisoni R, Calhoun DA. Current options for the treatment of resistant hypertension. Expert Rev Cardiovasc Ther. 2009 Nov; 7(11):1385-93. PMID: 19900021.
      Citations: 1     Fields:    Translation:Humans
    189. Feng W, Nagaraj H, Gupta H, Lloyd SG, Aban I, Perry GJ, Calhoun DA, Dell'Italia LJ, Denney TS. A dual propagation contours technique for semi-automated assessment of systolic and diastolic cardiac function by CMR. J Cardiovasc Magn Reson. 2009 Aug 13; 11:30. PMID: 19674481.
      Citations: 28     Fields:    Translation:Humans
    190. Calhoun DA. Use of single-pill combination therapy in the evolving paradigm of hypertension management. Expert Opin Pharmacother. 2009 Aug; 10(12):1869-74. PMID: 19496740.
      Citations: 4     Fields:    Translation:Humans
    191. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009 Sep; 54(3):475-81. PMID: 19620517.
      Citations: 168     Fields:    Translation:Humans
    192. Acelajado MC, Calhoun DA. Resistant hypertension: who and how to evaluate. Curr Opin Cardiol. 2009 Jul; 24(4):340-4. PMID: 19395953.
      Citations: 2     Fields:    Translation:Humans
    193. Calhoun DA, Lacourci?re Y, Chiang YT, Glazer RD. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension. 2009 Jul; 54(1):32-9. PMID: 19470877.
      Citations: 53     Fields:    Translation:Humans
    194. Pimenta E, Calhoun DA, Oparil S. Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis. 2009 Mar-Apr; 51(5):371-80. PMID: 19249443.
      Citations: 19     Fields:    Translation:HumansAnimals
    195. Pimenta E, Calhoun DA. Aldosterone and metabolic dysfunction: an unresolved issue. Hypertension. 2009 Apr; 53(4):585-6. PMID: 19221210.
      Citations: 6     Fields:    Translation:HumansAnimals
    196. Gaddam KK, Pimenta E, Husain S, Calhoun DA. Aldosterone and cardiovascular disease. Curr Probl Cardiol. 2009 Feb; 34(2):51-84. PMID: 19135616.
      Citations: 19     Fields:    Translation:HumansAnimals
    197. Flack JM, Calhoun DA, Satlin L, Barbier M, Hilkert R, Brunel P. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. J Hum Hypertens. 2009 Jul; 23(7):479-89. PMID: 19190658.
      Citations: 26     Fields:    Translation:Humans
    198. Gonzaga CC, Calhoun DA. Resistant hypertension and hyperaldosteronism. Curr Hypertens Rep. 2008 Dec; 10(6):496-503. PMID: 18959838.
      Citations: 10     Fields:    Translation:Humans
    199. Calhoun DA, White WB. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. J Am Soc Hypertens. 2008 Nov-Dec; 2(6):462-8. PMID: 20409927.
      Citations: 38     Fields:    
    200. Biederman RW, Doyle M, Young AA, Devereux RB, Kortright E, Perry G, Bella JN, Oparil S, Calhoun D, Pohost GM, Dell'Italia LJ. Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy. Hypertension. 2008 Aug; 52(2):279-86. PMID: 18606908.
      Citations: 13     Fields:    Translation:Humans
    201. Gonzaga CC, Calhoun DA. 2008 American Heart Association Statement on diagnosis, evaluation, and treatment of resistant hypertension: what should we remember in everyday practice? Pol Arch Med Wewn. 2008 Jul-Aug; 118(7-8):396-7. PMID: 18714732.
      Citations: 3     Fields:    Translation:Humans
    202. Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension. Curr Med Res Opin. 2008 Aug; 24(8):2303-11. PMID: 18593517.
      Citations: 5     Fields:    Translation:Humans
    203. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008 Jun 24; 117(25):e510-26. PMID: 18574054.
      Citations: 422     Fields:    Translation:Humans
    204. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med. 2008 Jun 09; 168(11):1159-64. PMID: 18541823.
      Citations: 95     Fields:    Translation:Humans
    205. White WB, Calhoun DA, Samuel R, Taylor AA, Zappe DH, Purkayastha D. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial. J Clin Hypertens (Greenwich). 2008 Jun; 10(6):450-8. PMID: 18550935.
      Citations: 7     Fields:    Translation:Humans
    206. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008 Jun; 51(6):1403-19. PMID: 18391085.
      Citations: 473     Fields:    Translation:Humans
    207. Li S, Chen SC, Shlipak M, Bakris G, McCullough PA, Sowers J, Stevens L, Jurkovitz C, McFarlane S, Norris K, Vassalotti J, Klag MJ, Brown WW, Narva A, Calhoun D, Johnson B, Obialo C, Whaley-Connell A, Becker B, Collins AJ. Low birth weight is associated with chronic kidney disease only in men. Kidney Int. 2008 Mar; 73(5):637-42. PMID: 18094674.
      Citations: 44     Fields:    Translation:Humans
    208. Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Aban I, Oparil S, Calhoun DA. Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension. 2008 Feb; 51(2):339-44. PMID: 18086955.
      Citations: 26     Fields:    Translation:Humans
    209. Pimenta E, Calhoun DA. Resistant hypertension and aldosteronism. Curr Hypertens Rep. 2007 Nov; 9(5):353-9. PMID: 18177580.
      Citations: 20     Fields:    Translation:Humans
    210. Ahmed A, Calhoun D. High blood pressure in older adults: a conversation with Dr David Calhoun. Am J Geriatr Cardiol. 2007 Nov-Dec; 16(6):391-2. PMID: 17975332.
      Citations:    Fields:    Translation:Humans
    211. Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Cofield SS, Oparil S, Calhoun DA. Aldosterone excess and resistance to 24-h blood pressure control. J Hypertens. 2007 Oct; 25(10):2131-7. PMID: 17885558.
      Citations: 12     Fields:    Translation:Humans
    212. Calhoun DA. Is there an unrecognized epidemic of primary aldosteronism? Pro. Hypertension. 2007 Sep; 50(3):447-53; discussion 447-53. PMID: 17679651.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    213. Pimenta E, Calhoun DA, Oparil S. Mechanisms and treatment of resistant hypertension. Arq Bras Cardiol. 2007 Jun; 88(6):683-92. PMID: 17664996.
      Citations: 5     Fields:    Translation:Humans
    214. Epstein M, Calhoun DA. The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy. Curr Hypertens Rep. 2007 Apr; 9(2):98-105. PMID: 17442219.
      Citations: 8     Fields:    Translation:Humans
    215. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007 Feb; 131(2):453-9. PMID: 17296647.
      Citations: 117     Fields:    Translation:Humans
    216. Calhoun DA. Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension. J Clin Hypertens (Greenwich). 2007 Jan; 9(1 Suppl 1):19-24. PMID: 17215651.
      Citations: 9     Fields:    Translation:Humans
    217. Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide. J Hypertens. 2007 Jan; 25(1):217-26. PMID: 17143194.
      Citations: 71     Fields:    Translation:Humans
    218. Calhoun DA. Aldosterone and cardiovascular disease: smoke and fire. Circulation. 2006 Dec 12; 114(24):2572-4. PMID: 17159070.
      Citations: 18     Fields:    Translation:Humans
    219. Pimenta E, Calhoun DA. Primary aldosteronism: diagnosis and treatment. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):887-93. PMID: 17170615.
      Citations: 4     Fields:    Translation:Humans
    220. Calhoun DA. Aldosteronism and hypertension. Clin J Am Soc Nephrol. 2006 Sep; 1(5):1039-45. PMID: 17699324.
      Citations: 23     Fields:    Translation:HumansPHPublic Health
    221. Pimenta E, Calhoun DA. Aldosterone, dietary salt, and renal disease. Hypertension. 2006 Aug; 48(2):209-10. PMID: 16801481.
      Citations: 7     Fields:    Translation:HumansAnimals
    222. Kalyankar ND, Sharma MK, Vaidya SV, Calhoun D, Maldarelli C, Couzis A, Gilchrist L. Arraying of intact liposomes into chemically functionalized microwells. Langmuir. 2006 Jun 06; 22(12):5403-11. PMID: 16732670.
      Citations: 5     Fields:    
    223. Calhoun DA. Use of aldosterone antagonists in resistant hypertension. Prog Cardiovasc Dis. 2006 May-Jun; 48(6):387-96. PMID: 16714158.
      Citations: 15     Fields:    Translation:Humans
    224. Gaddam KK, Pratt-Ubunama MN, Calhoun DA. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension. Expert Rev Cardiovasc Ther. 2006 May; 4(3):353-9. PMID: 16716096.
      Citations: 4     Fields:    Translation:Humans
    225. Nishizaka MK, Calhoun DA. Cardiovascular risk of systolic versus diastolic blood pressure in Western and non-Western countries. J Hypertens. 2006 Mar; 24(3):435-6. PMID: 16467642.
      Citations:    Fields:    Translation:Humans
    226. Calhoun DA. Resistant or difficult-to-treat hypertension. J Clin Hypertens (Greenwich). 2006 Mar; 8(3):181-6. PMID: 16522995.
      Citations: 8     Fields:    Translation:Humans
    227. Nishizaka MK, Calhoun DA. Primary aldosteronism: diagnostic and therapeutic considerations. Curr Cardiol Rep. 2005 Nov; 7(6):412-7. PMID: 16256009.
      Citations: 1     Fields:    Translation:Humans
    228. Nishizaka MK, Calhoun DA. The role of aldosterone antagonists in the management of resistant hypertension. Curr Hypertens Rep. 2005 Oct; 7(5):343-7. PMID: 16157075.
      Citations: 7     Fields:    Translation:Humans
    229. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005 Jun 15; 293(23):2884-91. PMID: 15956633.
      Citations: 82     Fields:    Translation:HumansCellsCTClinical Trials
    230. Pratt-Ubunama MN, Nishizaka MK, Calhoun DA. Aldosterone antagonism: an emerging strategy for effective blood pressure lowering. Curr Hypertens Rep. 2005 Jun; 7(3):186-92. PMID: 15913492.
      Citations:    Fields:    Translation:Humans
    231. Berecek KH, Calhoun D. Clinical trials report. Metabolic effects of carvedilol versus metoprolol in patients with type 2 diabetes mellitus and hypertension. Curr Hypertens Rep. 2005 Jun; 7(3):204-5. PMID: 15913495.
      Citations:    Fields:    
    232. Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens. 2005 Jun; 18(6):805-12. PMID: 15925740.
      Citations: 36     Fields:    Translation:Humans
    233. Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, Nesbitt S, Michelson E, Julius S. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12. PMID: 15691610.
      Citations: 8     Fields:    Translation:Humans
    234. Calhoun DA, Grassi G. Weight gain and hypertension: the chicken-egg question revisited. J Hypertens. 2004 Oct; 22(10):1869-71. PMID: 15361756.
      Citations: 2     Fields:    Translation:Humans
    235. Nishizaka MK, Calhoun DA. Use of aldosterone antagonists in resistant hypertension. J Clin Hypertens (Greenwich). 2004 Aug; 6(8):458-60. PMID: 15308885.
      Citations: 2     Fields:    Translation:Humans
    236. Nishizaka MK, Zaman MA, Green SA, Renfroe KY, Calhoun DA. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation. 2004 Jun 15; 109(23):2857-61. PMID: 15173035.
      Citations: 72     Fields:    Translation:Humans
    237. Jin M, Rosario W, Watler E, Calhoun DH. Development of a large-scale HPLC-based purification for the urease from Staphylococcus leei and determination of subunit structure. Protein Expr Purif. 2004 Mar; 34(1):111-7. PMID: 14766306.
      Citations: 4     Fields:    Translation:Cells
    238. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension. 2004 Mar; 43(3):518-24. PMID: 14732721.
      Citations: 74     Fields:    Translation:Humans
    239. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. 2004 Jan; 125(1):112-7. PMID: 14718429.
      Citations: 79     Fields:    Translation:Humans
    240. Hicken BL, Calhoun DA, Barton JC, Tucker DC. Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis. Genet Test. 2004; 8(2):90-7. PMID: 15345103.
      Citations: 4     Fields:    Translation:Humans
    241. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003 Nov 04; 139(9):761-76. PMID: 14597461.
      Citations: 187     Fields:    Translation:Humans
    242. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003 Nov; 16(11 Pt 1):925-30. PMID: 14573330.
      Citations: 144     Fields:    Translation:HumansCTClinical Trials
    243. Aqel RA, Zoghbi GJ, Baldwin SA, Auda WS, Calhoun DA, Coffey CS, Perry GJ, Iskandrian AE. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens. 2003 Jun; 21(6):1157-62. PMID: 12777953.
      Citations: 11     Fields:    Translation:Humans
    244. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002 Dec; 40(6):892-6. PMID: 12468575.
      Citations: 215     Fields:    Translation:HumansCTClinical Trials
    245. Bakris G, Calhoun D, Egan B, Hellmann C, Dolker M, Kingma I. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension. J Hypertens. 2002 Nov; 20(11):2257-67. PMID: 12409965.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    246. White WB, Sica DA, Calhoun D, Mansoor GA, Anders RJ. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. Am Heart J. 2002 Oct; 144(4):657-65. PMID: 12360162.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    247. Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov. 2002 Aug; 1(8):621-36. PMID: 12402502.
      Citations: 135     Fields:    Translation:HumansAnimals
    248. Calhoun DA, Zaman MA, Nishizaka MK. Resistant hypertension. Curr Hypertens Rep. 2002 Jun; 4(3):221-8. PMID: 12003705.
      Citations: 11     Fields:    Translation:Humans
    249. DeJesus V, Rios I, Davis C, Chen Y, Calhoun D, Zakeri Z, Hubbard K. Induction of apoptosis in human replicative senescent fibroblasts. Exp Cell Res. 2002 Mar 10; 274(1):92-9. PMID: 11855860.
      Citations: 4     Fields:    Translation:HumansCells
    250. Grassi G, Calhoun DA. Sympathetic-vascular interactions: further evidence in kidney transplantation. J Hypertens. 2002 Mar; 20(3):379-81. PMID: 11875301.
      Citations:    Fields:    Translation:HumansAnimals
    251. Maheshwari A, Christensen RD, Calhoun DA. Immune-mediated neutropenia in the neonate. Acta Paediatr Suppl. 2002; 91(438):98-103. PMID: 12477271.
      Citations: 15     Fields:    Translation:Humans
    252. Carter AR, Zhou ZH, Calhoun DA, Bubien JK. Hyperactive ENaC identifies hypertensive individuals amenable to amiloride therapy. Am J Physiol Cell Physiol. 2001 Nov; 281(5):C1413-21. PMID: 11600403.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    253. Calhoun DA, Wei CC, Zhu S, Bradley WE, Dell'Italia LJ. Enalaprilat blunts reflexive increases in cardiac interstitial norepinephrine in conscious rats. J Hypertens. 2001 Nov; 19(11):2025-9. PMID: 11677368.
      Citations:    Fields:    Translation:AnimalsCells
    254. Papoff P, Christensen RD, Calhoun DA, Juul SE. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome. Biol Neonate. 2001 Aug; 80(2):133-41. PMID: 11509813.
      Citations: 6     Fields:    Translation:HumansCells
    255. Elliott WJ, Calhoun DA, DeLucca PT, Gazdick LP, Kerns DE, Zeldin RK. Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial. Clin Ther. 2001 Aug; 23(8):1166-79. PMID: 11558856.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    256. Calhoun DA, Gersting JA, Lun?e M, Du Y, Christensen RD. Transfer of recombinant human granulocyte colony stimulating factor (rhG-CSF) from the maternal to the fetal circulation is not dependent upon a functional G-CSF-receptor. Placenta. 2001 Jul; 22(6):609-12. PMID: 11440552.
      Citations: 4     Fields:    Translation:HumansAnimals
    257. Bernstein HM, Pollock BH, Calhoun DA, Christensen RD. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis. J Pediatr. 2001 Jun; 138(6):917-20. PMID: 11391341.
      Citations: 10     Fields:    Translation:Humans
    258. Payami H, Lee N, Zareparsi S, Gonzales McNeal M, Camicioli R, Bird TD, Sexton G, Gancher S, Kaye J, Calhoun D, Swanson PD, Nutt J. Parkinson's disease, CYP2D6 polymorphism, and age. Neurology. 2001 May 22; 56(10):1363-70. PMID: 11376189.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    259. Calhoun DA, Chegini N, Polliotti BM, Gersting JA, Miller RK, Christensen RD. Granulocyte colony-stimulating factor in preterm and term pregnancy, parturition, and intra-amniotic infection. Obstet Gynecol. 2001 Feb; 97(2):229-34. PMID: 11165587.
      Citations: 10     Fields:    Translation:Humans
    260. Sakawi Y, Tarpey M, Chen YF, Calhoun DA, Connor MG, Chestnut DH, Parks DA. Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia. Anesthesiology. 2000 Dec; 93(6):1446-55. PMID: 11149440.
      Citations: 7     Fields:    Translation:Animals
    261. Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates. Ann Pharmacother. 2000 Nov; 34(11):1257-61. PMID: 11098337.
      Citations:    Fields:    Translation:Humans
    262. Calhoun DA, Christensen RD. Human developmental biology of granulocyte colony-stimulating factor. Clin Perinatol. 2000 Sep; 27(3):559-76, vi. PMID: 10986629.
      Citations: 4     Fields:    Translation:HumansCells
    263. Christensen RD, Calhoun DA, Rimsza LM. A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit. Clin Perinatol. 2000 Sep; 27(3):577-601. PMID: 10986630.
      Citations: 7     Fields:    Translation:HumansCells
    264. Sullivan SE, Calhoun DA. Eosinophilia in the neonatal intensive care unit. Clin Perinatol. 2000 Sep; 27(3):603-22, vi. PMID: 10986631.
      Citations: 2     Fields:    Translation:HumansCells
    265. Calhoun DA, Christensen RD, Edstrom CS, Juul SE, Ohls RK, Schibler KR, Sola MC, Sullivan SE. Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol. 2000 Sep; 27(3):733-53. PMID: 10986638.
      Citations: 11     Fields:    Translation:HumansCells
    266. Edstrom CS, Calhoun DA, Christensen RD. Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev. 2000 Aug; 59(2):77-84. PMID: 10996745.
      Citations: 11     Fields:    Translation:HumansCells
    267. Calhoun DA, Sullivan SE, Lun?e M, Du Y, Christensen RD. Granulocyte-macrophage colony-stimulating factor and interleukin-5 concentrations in premature neonates with eosinophilia. J Perinatol. 2000 Apr-May; 20(3):166-71. PMID: 10802841.
      Citations: 2     Fields:    Translation:HumansCells
    268. Calhoun DA, Lun?e M, Du Y, Hutson AD, Veerman M, Christensen RD. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor. Pediatrics. 2000 Feb; 105(2):392-7. PMID: 10654961.
      Citations:    Fields:    Translation:HumansCells
    269. Calhoun DA, Lunoe M, Du Y, Christensen RD. Granulocyte colony-stimulating factor is present in human milk and its receptor is present in human fetal intestine. Pediatrics. 2000 Jan; 105(1):e7. PMID: 10617744.
      Citations: 17     Fields:    Translation:Humans
    270. Calhoun DA, Lun?e M, Du Y, Staba SL, Christensen RD. Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion. Pediatr Res. 1999 Dec; 46(6):767-71. PMID: 10590037.
      Citations: 9     Fields:    Translation:Humans
    271. Alper AB, Calhoun DA. Contemporary management of refractory hypertension. Curr Hypertens Rep. 1999 Oct; 1(5):402-7. PMID: 10981097.
      Citations: 2     Fields:    Translation:Humans
    272. Calhoun DA, Donnelly WH, Du Y, Dame JB, Li Y, Christensen RD. Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus. Pediatr Res. 1999 Sep; 46(3):333-8. PMID: 10473051.
      Citations: 6     Fields:    Translation:Humans
    273. Tebes CC, Mehta P, Calhoun DA, Richards DS. Congenital ischemic forearm necrosis associated with a compound presentation. J Matern Fetal Med. 1999 Sep-Oct; 8(5):231-3. PMID: 10475507.
      Citations: 4     Fields:    Translation:Humans
    274. Fang Z, Sripairojthikoon W, Calhoun DA, Zhu S, Berecek KH, Wyss JM. Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats. J Hypertens. 1999 Jul; 17(7):983-91. PMID: 10419072.
      Citations: 6     Fields:    Translation:Animals
    275. Calhoun DA, Zhu S. Pretreatment with enalaprilat blunts nicardipine-induced sympathetic activation in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 1999 Apr; 17(4):507-12. PMID: 10404952.
      Citations: 4     Fields:    Translation:Animals
    276. Sola MC, Calhoun DA, Hutson AD, Christensen RD. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol. 1999 Jan; 104(1):90-2. PMID: 10027717.
      Citations: 11     Fields:    Translation:Humans
    277. Sola MC, Juul SE, Meng YG, Garg S, Sims P, Calhoun DA, Dame JB, Christensen D. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Hum Dev. 1999 Jan; 53(3):239-50. PMID: 10088990.
      Citations: 4     Fields:    Translation:Humans
    278. Slayton WB, Li Y, Calhoun DA, Juul SE, Iturraspe J, Braylan RC, Christensen RD. The first-appearance of neutrophils in the human fetal bone marrow cavity. Early Hum Dev. 1998 Dec; 53(2):129-44. PMID: 10195706.
      Citations: 14     Fields:    Translation:HumansCells
    279. Calhoun DA, Christensen RD. A randomized pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery. Am J Obstet Gynecol. 1998 Sep; 179(3 Pt 1):766-71. PMID: 9757987.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    280. Juul SE, Calhoun DA, Christensen RD. "Idiopathic neutropenia" in very low birthweight infants. Acta Paediatr. 1998 Sep; 87(9):963-8. PMID: 9764892.
      Citations: 2     Fields:    Translation:Humans
    281. Slayton WB, Juul SE, Calhoun DA, Li Y, Braylan RC, Christensen RD. Hematopoiesis in the liver and marrow of human fetuses at 5 to 16 weeks postconception: quantitative assessment of macrophage and neutrophil populations. Pediatr Res. 1998 Jun; 43(6):774-82. PMID: 9621987.
      Citations: 4     Fields:    Translation:HumansCells
    282. Oparil S, Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician. 1998 Mar 01; 57(5):1007-14, 1019-20. PMID: 9518949.
      Citations: 8     Fields:    Translation:Humans
    283. Calhoun DA, Christensen RD. Recent advances in the pathogenesis and treatment of nonimmune neutropenias in the neonate. Curr Opin Hematol. 1998 Jan; 5(1):37-41. PMID: 9515201.
      Citations: 1     Fields:    Translation:HumansCells
    284. Calhoun DA, Mutinga ML. Race, family history of hypertension, and sympathetic response to cold pressor testing. Blood Press. 1997 Jul; 6(4):209-13. PMID: 9296307.
      Citations: 22     Fields:    Translation:Humans
    285. Calhoun DA, Oparil S. High blood pressure in women. Int J Fertil Womens Med. 1997 May-Jun; 42(3):198-205. PMID: 9222804.
      Citations: 1     Fields:    Translation:Humans
    286. Calhoun DA, Christensen RD. The occurrence of Kostmann syndrome in preterm neonates. Pediatrics. 1997 Feb; 99(2):259-61. PMID: 9024459.
      Citations:    Fields:    Translation:Humans
    287. Calhoun DA, Li Y, Christensen RD. Effect of recombinant granulocyte colony-stimulating factor on erythropoiesis in the human fetus and neonate. Pediatr Res. 1996 Dec; 40(6):872-5. PMID: 8947965.
      Citations:    Fields:    Translation:HumansAnimalsCells
    288. Calhoun DA, Li Y, Braylan RC, Christensen RD. Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus. Early Hum Dev. 1996 Nov 21; 46(3):217-27. PMID: 8922566.
      Citations: 6     Fields:    Translation:HumansCells
    289. Li Y, Calhoun DA, Polliotti BM, Sola MC, al-Mulla Z, Christensen RD. Production of granulocyte colony-stimulating factor by the human placenta at various stages of development. Placenta. 1996 Nov; 17(8):611-7. PMID: 8916210.
      Citations: 2     Fields:    Translation:HumansCells
    290. Calhoun DA, Kirk JF, Christensen RD. Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation. J Pediatr. 1996 Sep; 129(3):403-9. PMID: 8804330.
      Citations: 3     Fields:    Translation:Humans
    291. Li Y, Juul SE, Morris-Wiman JA, Calhoun DA, Christensen RD. Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses. Pediatr Res. 1996 Sep; 40(3):376-80. PMID: 8865271.
      Citations: 7     Fields:    Translation:HumansCells
    292. Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol. 1996 Apr; 174(4):1306-11. PMID: 8623861.
      Citations: 9     Fields:    Translation:HumansCells
    293. Zhu ST, Chen YF, Wyss JM, Nakao K, Imura H, Oparil S, Calhoun DA. Atrial natriuretic peptide blunts arterial baroreflex in spontaneously hypertensive rats. Hypertension. 1996 Feb; 27(2):297-302. PMID: 8567055.
      Citations:    Fields:    Translation:Animals
    294. Calhoun DA, Oparil S. Racial differences in the pathogenesis of hypertension. Am J Med Sci. 1995 Dec; 310 Suppl 1:S86-90. PMID: 7503132.
      Citations: 13     Fields:    Translation:HumansAnimals
    295. Calhoun DA, Christensen RD. Commonly asked questions regarding infections in neonates. Pediatr Ann. 1995 Nov; 24(11):583-6, 589-91. PMID: 8570296.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    296. Calhoun DA, Zhu ST, Chen YF, Oparil S. Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1995 Aug; 26(2):285-9. PMID: 7635536.
      Citations: 7     Fields:    Translation:Animals
    297. Calhoun DA, Oparil S. Hypertensive crisis since FDR--a partial victory. N Engl J Med. 1995 Apr 13; 332(15):1029-30. PMID: 7885411.
      Citations: 1     Fields:    Translation:Humans
    298. Calhoun DA, Mutinga ML, Wyss JM, Oparil S. Muscle sympathetic nervous system activity in black and Caucasian hypertensive subjects. J Hypertens. 1994 Nov; 12(11):1291-6. PMID: 7868877.
      Citations: 8     Fields:    Translation:Humans
    299. Calhoun DA, Zhu S, Wyss JM, Oparil S. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. Hypertension. 1994 Jul; 24(1):1-7. PMID: 8020996.
      Citations: 11     Fields:    Translation:Animals
    300. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994 Jul; 90(1):248-53. PMID: 8026005.
      Citations: 90     Fields:    Translation:Humans
    301. Grassi G, Seravalle G, Calhoun DA, Mancia G. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension. 1994 Mar; 23(3):294-301. PMID: 8125553.
      Citations: 34     Fields:    Translation:HumansCells
    302. Calhoun DA, Mutinga ML, Collins AS, Wyss JM, Oparil S. Normotensive blacks have heightened sympathetic response to cold pressor test. Hypertension. 1993 Dec; 22(6):801-5. PMID: 8244512.
      Citations: 36     Fields:    Translation:Humans
    303. Nakamura Y, Calhoun DA, Chen YF, Wyss JM, Oparil S. Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats. Hypertension. 1993 Sep; 22(3):285-91. PMID: 8349320.
      Citations: 1     Fields:    Translation:Animals
    304. Calhoun DA. Hypertension in blacks: socioeconomic stress and sympathetic nervous system activity. Am J Med Sci. 1992 Nov; 304(5):306-11. PMID: 1442872.
      Citations: 14     Fields:    Translation:Humans
    305. Jin H, Yang RH, Calhoun DA, Wyss JM, Oparil S. Atrial natriuretic peptide modulates baroreceptor reflex in spontaneously hypertensive rat. Hypertension. 1992 Sep; 20(3):374-9. PMID: 1387631.
      Citations: 1     Fields:    Translation:AnimalsCells
    306. Grassi G, Seravalle G, Calhoun DA, Matturri M, Mancia G, Zanchetti A. Monitoring of sympathetic activity in man: physiology and pharmacology. Eur Heart J. 1992 Jun; 13 Suppl A:22-5. PMID: 1396847.
      Citations: 2     Fields:    Translation:Humans
    307. Grassi G, Seravalle G, Calhoun D, Bolla GB, Mancia G. Physical exercise in essential hypertension. Chest. 1992 May; 101(5 Suppl):312S-314S. PMID: 1576856.
      Citations: 6     Fields:    Translation:Humans
    308. Grassi G, Seravalle G, Calhoun DA, Bolla G, Mancia G. Cigarette smoking and the adrenergic nervous system. Clin Exp Hypertens A. 1992; 14(1-2):251-60. PMID: 1541039.
      Citations: 11     Fields:    Translation:Humans
    309. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Zanchetti A, Mancia G. Alterations in sympathetic nerve traffic during cigarette-smoking in man: a preliminary report. J Hypertens Suppl. 1991 Dec; 9(6):S52-3. PMID: 1819010.
      Citations:    Fields:    Translation:Humans
    310. Oparil S, Calhoun DA. The calcium antagonists in the 1990s. An overview. Am J Hypertens. 1991 Jul; 4(7 Pt 2):396S-405S. PMID: 1910636.
      Citations: 1     Fields:    Translation:HumansAnimals
    311. Calhoun DA, Wyss JM, Oparil S. High NaCl diet enhances arterial baroreceptor reflex in NaCl-sensitive spontaneously hypertensive rats. Hypertension. 1991 Mar; 17(3):363-8. PMID: 1999366.
      Citations:    Fields:    Translation:AnimalsCells
    312. Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med. 1990 Oct 25; 323(17):1177-83. PMID: 2215596.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    313. Oparil S, Calhoun DA. Hypertension. Dis Mon. 1989 Mar; 35(3):133-232. PMID: 2565199.
      Citations:    Fields:    Translation:Humans
    Calhoun's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (717)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support